FARA Celebrates 16 Years of Funding Adaptive Cycling Equipment Through The Ataxian Athlete Initiative (AAI)
rideATAXIA
United Against Ataxia Hill Day 2024 – Registration open!
Advocacy | FARA News
August 2024 – Advocacy Newsletter
Advocacy
Join us for FA Community Conversations – Genetic Medicine on August 29, 2024
Education
Larimar Therapeutics Reports Several Updates on Nomlabofusp FA Program in Q2 2024 Operating and Financial Results
Industry News
Job Opening – Accounting Specialist
FARA News
FARA Advocates for Effective Inclusion of Children Early in Clinical Trials at Pediatric Inclusion Roundtable
Advocacy | FARA News
2023 Donor Impact Report
FARA News
LEXEO Therapeutics Announces Positive Interim Phase 1/2 Clinical Data of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy
Industry News
June 2024 – Advocacy Newsletter
Advocacy
C-Path Partners with FARA to Fortify RDCA-DAP and Further Accelerate Drug Development with new Friedreich’s Ataxia Data
Partner News
Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia
Industry News